Leon Kircik

Search results

• Cal/BDP cream preferred over foam formulation among patients with psoriasis

  Kircik, L.

  20/08/24

  1 item of Media coverage

  Press/Media

• Isotretinoin formulation for acne administered without food may increase patient adherence

  Kircik, L.

  8/07/24

  1 item of Media coverage

  Press/Media

• Data from Icahn School of Medicine at Mount Sinai Provide New Insights into Acne Vulgaris (Triple Combination Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% for Acne: Efficacy and Safety from a Pooled Phase 3 Analysis)

  Kircik, L.

  6/06/24

  1 item of Media coverage

  Press/Media

• Triple-Combination Acne Treatment Gel Effective, Well-Tolerated Among Patients; The treatment, made up of clindamycin phosphate, adapalene, and benzoyl peroxide, led to clear or almost clear skin among a significant number of individuals with acne.

  Kircik, L.

  13/05/24

  2 items of Media coverage

  Press/Media

• Triple-Combination Acne Treatment Gel Effective, Well-Tolerated Among Patients

  Kircik, L.

  13/05/24

  3 items of Media coverage

  Press/Media

• Studies from Icahn School of Medicine at Mount Sinai in the Area of Psoriasis Reported (Once-daily Roflumilast Foam 0.3% for Scalp and Body Psoriasis: a Randomized, Double-blind, Vehicle-controlled Phase Iib Study)

  Kircik, L.

  16/04/24

  1 item of Media coverage

  Press/Media

• Discovering Dermatology Times: March 2024 Enhancing Psoriasis Management Supplement

  Kircik, L.

  1/03/24

  1 item of Media coverage

  Press/Media

• Frontline Forum Part 1: Challenges and Opportunities to Enhance Psoriasis Management

  Kircik, L.

  1/03/24

  1 item of Media coverage

  Press/Media

• Applying moisturizer before HP/TAZ for psoriasis may improve tolerability

  Kircik, L.

  26/02/24

  1 item of Media coverage

  Press/Media

• Report Summarizes Pruritus Study Findings from Icahn School of Medicine at Mount Sinai (Rapid Improvements In Itch With Tapinarof Cream 1% Once Daily In Two Phase 3 Trials In Adults With Mild To Severe Plaque Psoriasis)

  Kircik, L.

  24/01/24

  1 item of Media coverage

  Press/Media

• January 9th 2024

  Kircik, L.

  9/01/24

  1 item of Media coverage

  Press/Media

• Safety Considerations in Emerging Biologic Treatments for Plaque Psoriasis

  Kircik, L.

  1/01/24

  3 items of Media coverage

  Press/Media

• December 21st 2023

  Kircik, L.

  21/12/23

  1 item of Media coverage

  Press/Media

• Dermatology Times 2023 In Review: Acne

  Kircik, L.

  1/12/23

  1 item of Media coverage

  Press/Media

• Frontline Forum Sneak Peek: Expert Insights on Psoriasis Treatment Guidelines

  Kircik, L.

  1/12/23

  1 item of Media coverage

  Press/Media

• Expert Insights into Emerging Oral Psoriasis Treatments

  Kircik, L.

  1/12/23

  1 item of Media coverage

  Press/Media

• Navigating TYK-2 Inhibitor Use for Psoriasis Maintenance and Long-Term Benefits

  Kircik, L.

  1/12/23

  1 item of Media coverage

  Press/Media

• -Nektar Therapeutics Announces Two Abstracts Accepted at EADV Congress 2023 for Rezpegaldesleukin, a First-in-Class Selective Regulatory T-cell Therapy

  Kircik, L.

  3/10/23

  2 items of Media coverage

  Press/Media

• Nektar Therapeutics Announces Two Abstracts Accepted at EADV Congress 2023 for Rezpegaldesleukin, a First-in-Class Selective Regulatory T-cell Therapy

  Kircik, L.

  2/10/23

  1 item of Media coverage

  Press/Media

• Nektar Therapeutics Announces Two Abstracts Accepted At EADV Congress 2023 For Rezpegaldesleukin, A First-In-Class Selective Regulatory T-cell Therapy

  Kircik, L.

  2/10/23

  47 items of Media coverage

  Press/Media

• Reports on Telemedicine Findings from Donald and Barbara Zucker School of Medicine at Hofstra Provide New Insights (National Psoriasis Foundation Telemedicine Task Force guidance for management of psoriatic disease via telemedicineCapsule ...)

  Kircik, L.

  7/09/23

  1 item of Media coverage

  Press/Media

• Salicylic acid, ceramides-containing moisturizers may be adjuvant therapies for psoriasis

  Kircik, L.

  17/08/23

  1 item of Media coverage

  Press/Media

• The Weekly Roundup: August 21-25

  Kircik, L.

  1/08/23

  1 item of Media coverage

  Press/Media

• Aslan hopes fewer side effects can catapult atopic dermatitis med over Dupixent after mixed readout

  Kircik, L.

  6/07/23

  1 item of Media coverage

  Press/Media

• Icahn School of Medicine at Mount Sinai Researcher Updates Knowledge of Psoriasis (Once-daily roflumilast foam 0.3% for scalp and body psoriasis: A randomized, double-blind, vehicle-controlled phase 2b study)

  Kircik, L.

  27/06/23

  1 item of Media coverage

  Press/Media